Drägerwerk AG & Co. KGaA stock (DE0005550636): dividend hike follows annual meeting as investors watch valuation metrics

Drägerwerk AG & Co. KGaA recently secured shareholder approval for a significantly higher dividend at its 2026 annual general meeting, while the Lübeck-based medical and safety technology group continues to trade on the Xetra market in Germany with investors focusing on earnings power and valuation.

Drägerwerk AG & Co. KGaA, the German medical and safety technology specialist based in Lübeck, remains in focus for domestic investors after its most recent annual general meeting approved a clearly higher dividend and the preference share continues to trade actively on Xetra.

According to data for the preference share (WKN 555063, ISIN DE0005550636) on Xetra, the stock last changed hands at 91.70 EUR on 05/22/2026, with a modest day-on-day decline of 0.43% and around 770 shares traded by late morning, reflecting ongoing but relatively moderate liquidity in the German home market as reported by comdirect on 05/22/2026.comdirect as of 05/22/2026

At the annual general meeting held on 05/08/2026, shareholders approved a substantial increase in the dividend, with an EQS corporate news release via FinanzNachrichten on 05/08/2026 stating that the meeting resolved a marked dividend hike for Drägerwerk AG & Co. KGaA compared with the previous year, underscoring the company’s intention to return more cash to investors.FinanzNachrichten EQS-News as of 05/08/2026

In the broader German market context, the preference shares are also quoted on other domestic trading venues; finanzen.at cited a price of 92.50 EUR for the Drägerwerk preference share on 06/04/2026 in Frankfurt trading, representing an intraday change of 0.11% and highlighting that the stock is still closely tied to the German TecDAX environment even as indices fluctuate.finanzen.at as of 06/04/2026

As of: 06/05/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: Drägerwerk
• Sector/industry: Medical and safety technology
• Headquarters/country: Lübeck, Germany
• Core markets: Europe, North America, Asia-Pacific
• Key revenue drivers: Medical ventilation and monitoring systems, anesthesia workstations, and gas detection and personal safety equipment for industrial and public-sector customers
• Home exchange/listing venue: Xetra (ticker commonly quoted under 555063 as preference share)
• Trading currency: EUR

Drägerwerk AG & Co. KGaA: core business model

Drägerwerk focuses on designing and supplying medical technology for hospitals and safety solutions for industrial and emergency-services clients, generating revenue primarily from equipment sales and associated service contracts across Europe and other international regions.

Valuation metrics and multiples for Drägerwerk AG & Co. KGaA

For valuation-focused investors in Germany and abroad, Drägerwerk AG & Co. KGaA is often assessed through the lens of earnings power, balance sheet strength and market multiples such as price-to-earnings and enterprise-value-to-EBITDA ratios, even though these metrics fluctuate with quarterly results and updated guidance.

Based on recent prices in the low-90 EUR range for the preference share as quoted on Xetra and Frankfurt between 05/22/2026 and 06/04/2026, the market capitalization of the company’s listed equity implies that investors factor in both the cyclicality of demand for hospital equipment and safety systems and the more stable, long-term service and maintenance income streams that typically underpin cash flow in this sector.

Publicly available valuation snapshots from German financial portals in early June 2026 indicate that Drägerwerk’s preference shares trade at a level that reflects a balance between earnings recovery potential and competitive pressures in medical technology, with key ratios reacting to each new set of reported figures and to changes in the economic outlook for healthcare spending and industrial safety investments.finanzen.at as of 06/04/2026

Conclusion

The recent annual general meeting decision to significantly increase the dividend underlines Drägerwerk AG & Co. KGaA’s willingness to share more of its cash flow with shareholders, while the stock’s trading range around the low-90 EUR level on Xetra and Frankfurt keeps valuation in the spotlight for German investors.

With the company positioned in specialized medical and safety technologies and valuation metrics responding to each new data point, the interaction between dividend policy, earnings trends and market multiples will likely remain central to how the Drägerwerk preference share is viewed in the German equity market.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.